Stage IIIB Breast Cancer AJCC v7 Active Not Recruiting Phase 3 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02003209Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerTreatment